Population pharmacokinetics of unbound valproic acid in pediatric epilepsy patients in China: a protein binding model

[1]  L. Gibiansky,et al.  Mechanistic Population Pharmacokinetic Model of Oseltamivir and Oseltamivir Carboxylate Accounting for Physiological Changes to Predict Exposures in Neonates and Infants , 2020, Clinical pharmacology and therapeutics.

[2]  J. Sander,et al.  Epilepsy in adults , 2019, The Lancet.

[3]  Boting Zhou,et al.  Determination of unbound valproic acid in plasma using centrifugal ultrafiltration and gas chromatography:Application in TDM. , 2019, Analytical biochemistry.

[4]  W. Jiang,et al.  Association between SCN1A polymorphism rs3812718 and valproic acid resistance in epilepsy children: a case–control study and meta-analysis , 2018, Bioscience reports.

[5]  Yingjie Guo,et al.  Population pharmacokinetics of valproic acid in epileptic children: Effects of clinical and genetic factors , 2018, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[6]  Janthima Methaneethorn.  A systematic review of population pharmacokinetics of valproic acid , 2018, British journal of clinical pharmacology.

[7]  O. Dulac,et al.  A population pharmacokinetic model taking into account protein binding for the sustained-release granule formulation of valproic acid in children with epilepsy , 2018, European Journal of Clinical Pharmacology.

[8]  M. S. Mostafa,et al.  A rapid and simple procedure for monitoring valproic acid by gas chromatography , 2018 .

[9]  Hesham S. Al-Sallami,et al.  Choosing the Allometric Exponent in Covariate Model Building , 2018, Clinical Pharmacokinetics.

[10]  A. Frenette,et al.  Clinical Importance of Monitoring Unbound Valproic Acid Concentration in Patients with Hypoalbuminemia , 2017, Pharmacotherapy.

[11]  Janthima Methaneethorn.  Population Pharmacokinetics of Valproic Acid in Patients with Mania: Implication for Individualized Dosing Regimens. , 2017, Clinical therapeutics.

[12]  N. V. van Erp,et al.  Monitoring Protein-Unbound Valproic Acid Serum Concentrations in Clinical Practice , 2017, Therapeutic drug monitoring.

[13]  Meriem Bensalem-Owen,et al.  Pharmacokinetics and Clinical Utility of Valproic Acid Administered via Continuous Infusion , 2015, CNS Drugs.

[14]  Yi Wang,et al.  A Population Pharmacokinetic Model of Valproic Acid in Pediatric Patients with Epilepsy: A Non-Linear Pharmacokinetic Model Based on Protein-Binding Saturation , 2015, Clinical Pharmacokinetics.

[15]  Brahim Tabarki,et al.  Antiepileptic drugs , 2014, Reactions Weekly.

[16]  Li Su,et al.  Prevalence of epilepsy in the People's Republic of China: A systematic review , 2013, Epilepsy Research.

[17]  A. Collier,et al.  The Development of UDP-Glucuronosyltransferases 1A1 and 1A6 in the Pediatric Liver , 2011, Drug Metabolism and Disposition.

[18]  B. Anderson,et al.  A maturation model for midazolam clearance , 2011, Paediatric anaesthesia.

[19]  Edward H. Kerns,et al.  The effect of plasma protein binding on in vivo efficacy: misconceptions in drug discovery , 2010, Nature Reviews Drug Discovery.

[20]  C. Ji,et al.  [Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years]. , 2009, Zhonghua er ke za zhi = Chinese journal of pediatrics.

[21]  T. Sendo,et al.  Characterization of non‐linear relationship between total and unbound serum concentrations of valproic acid in epileptic children , 2008, Journal of clinical pharmacy and therapeutics.

[22]  D. Panomvana Na Ayudhya,et al.  Pharmacokinetic Parameters of Total and Unbound Valproic Acid and Their Relationships to Seizure Control in Epileptic Children , 2006, American journal of therapeutics.

[23]  Jae Eun Ahn,et al.  Inherent Correlation Between Dose and Clearance in Therapeutic Drug Monitoring Settings: Possible Misinterpretation in Population Pharmacokinetic Analyses , 2005, Journal of Pharmacokinetics and Pharmacodynamics.

[24]  P. Camfield,et al.  Management Guidelines for Children with Idiopathic Generalized Epilepsy , 2005, Epilepsia.

[25]  M. Perazella,et al.  Extracorporeal Management of Valproic Acid Toxicity: A Case Report and Review of the Literature , 2005, Seminars in dialysis.

[26]  B. Burchell,et al.  The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases. , 2003, Biochemical pharmacology.

[27]  V. Cosson,et al.  Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients , 2003, European Journal of Clinical Pharmacology.

[28]  L. Kramer,et al.  Elevated Free Fractions of Valproic Acid in a Heart Transplant Patient with Hypoalbuminemia , 2000, The Annals of pharmacotherapy.

[29]  J. Pellock,et al.  Treatment of absence status with intravenous valproate , 1999, Neurology.

[30]  A. Domínguez-Gil,et al.  Valproate population pharmacokinetics in children , 1999, Journal of clinical pharmacy and therapeutics.

[31]  G. Anderson,et al.  Bidirectional interaction of valproate and lamotrigine in healthy subjects , 1996, Clinical pharmacology and therapeutics.

[32]  B. Burchell,et al.  Substrate specificities of two stably expressed human liver UDP-glucuronosyltransferases of the UGT1 gene family. , 1993, Drug metabolism and disposition: the biological fate of chemicals.

[33]  M. Takeyama,et al.  Binding Parameters of Valproic Acid to Serum Protein in Healthy Adults at Steady State , 1992, Therapeutic Drug Monitoring.

[34]  S. Gupta,et al.  Pharmacokinetics of valproic acid after administration of three oral formulations in healthy adults. , 1990, The Journal of the Association of Physicians of India.

[35]  R. Hain,et al.  Morphine Metabolism in Children , 1990, British journal of clinical pharmacology.

[36]  I. Choonara,et al.  Morphine metabolism in children. , 1989 .

[37]  L. Bauer,et al.  Valproic acid clearance: Unbound fraction and diurnal variation in young and elderly adults , 1985, Clinical pharmacology and therapeutics.

[38]  M Lindsay,et al.  Epilepsy in adults. , 1983, Nursing.

[39]  HighWire Press,et al.  Drug metabolism and disposition : the biological fate of chemicals. , 1973 .